CAC / Camden National Corporation - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Camden National Corporation
US ˙ NasdaqGS ˙ US1330341082

Mga Batayang Estadistika
LEI 549300ZVEDL2L8UW4F28
CIK 750686
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Camden National Corporation
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
August 7, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 001-13227 CAMDEN NATIONAL CORPORATION (Exact name of registrant as sp

July 29, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 29, 2025 Camden National Cor

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 29, 2025 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 001-13227 01-0413282 (State or other jurisdiction of incorporation) (Commission

July 29, 2025 EX-99.1

Camden National Corporation Reports Second Quarter 2025 Earnings Net Income of $14.1 Million and Diluted EPS of $0.83 for the Second Quarter

CONTACT: Michael Archer Executive Vice President Chief Financial Officer Camden National Corporation (800) 860-8821 marcher@CamdenNational.

June 24, 2025 EX-99.1

Camden National Corporation Announces its Second Quarter 2025 Dividend

CONTACT: Michael Archer Executive Vice President Chief Financial Officer Camden National Corporation (800) 860-8821 marcher@CamdenNational.

June 24, 2025 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 24, 2025 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 001-13227 01-0413282 (State or other jurisdiction of incorporation) (Commission

May 23, 2025 S-8

As filed with the Securities and Exchange Commission on May 23, 2025 Registration Statement No. 333-

As filed with the Securities and Exchange Commission on May 23, 2025 Registration Statement No.

May 23, 2025 EX-4.4

Amendment to the Camden National Corporation 2022 Equity and Incentive Plan, effective as of May 20, 2025.*

Exhibit 4.4 FIRST AMENDMENT TO CAMDEN NATIONAL CORPORATION 2022 EQUITY AND INCENTIVE PLAN This amendment (this “Amendment”) to the Camden National Corporation 2022 Equity and Incentive Plan (the “Plan”) is made and adopted as of March 25, 2025 by the Board of Directors (the “Board”) of Camden National Corporation (the “Company”). 1.The first sentence of Section 3.1(a) of the Plan is hereby amended

May 23, 2025 EX-4.3

amden National Corporation 2022 Equity and Incentive Plan, effective as of April 26, 2022.

CAMDEN NATIONAL CORPORATION 2022 EQUITY AND INCENTIVE PLAN Table of Contents Page GENERAL PURPOSE OF THE PLAN 1 SECTION 1 DEFINITIONS 1 SECTION 2 ADMINISTRATION 5 (a) Committee.

May 23, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 20, 2025 Camden National Corp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 20, 2025 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 001-13227 01-0413282 (State or other jurisdiction of incorporation) (Commission F

May 23, 2025 EX-FILING FEES

Calculation of Filing Fee.*

Exhibit 107 CALCULATION OF FILING FEE TABLE Form S-8 Camden National Corporation Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price(2) Fee Rate Amount of Registration Fee Equity Common stock, no par value Rule 457(c) and Rule 457(h) 560,000 $41.

May 23, 2025 EX-24.1

Power of Attorney.*

Exhibit 24.1 POWER OF ATTORNEY Each person whose signature appears below hereby constitutes and appoints each of Simon R. Griffiths and Michael R. Archer, with full power to act without the other, his or her true and lawful attorney-in-fact and agent, with full power of substitution, for him or her and in his or her name, place and stead, in any and all capacities, to do any and all acts and thing

May 8, 2025 EX-10.1

ended and Restated Defined Contribution Retirement Program, effective

CAMDEN NATIONAL CORPORATION FOURTH AMENDED AND RESTATED DEFINED CONTRIBUTION RETIREMENT PROGRAM Effective March 28, 2025 This Camden National Corporation Fourth Amended and Restated Defined Contribution Retirement Program (the “Program”), effective as of March 28, 2025 is an amendment and restatement of the Camden National Corporation Third Amended and Restated Defined Contribution Retirement Plan, effective as of April 26.

May 8, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 001-13227 CAMDEN NATIONAL CORPORATION (Exact name of registrant as s

May 6, 2025 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 6, 2025 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission Fil

May 6, 2025 EX-99.2

Northway Transaction Assumptions ($ in millions excl. TBV / Share) Announcement September 2024 Actual Results & Updated Expectations as of March 31, 2025 Comments Deal Value $86.6 $96.5 Higher closing stock price of $42.25 at deal close on January 2,

Northway Transaction Assumptions ($ in millions excl. TBV / Share) Announcement September 2024 Actual Results & Updated Expectations as of March 31, 2025 Comments Deal Value $86.6 $96.5 Higher closing stock price of $42.25 at deal close on January 2, 2025 versus deal announcement stock price of $37.90 on September 9, 2024 Shares Issued 2,283,782 2,283,782 One-time charges $13.5 $12.5 - $13.5 $10.8

May 6, 2025 EX-99.1

Camden National Corporation Reports First Quarter 2025 Earnings Camden National Reaches $7.0 Billion in Total Assets as it Successfully Completes the Acquisition of Northway Financial, Inc. in the First Quarter

CONTACT: Michael Archer Executive Vice President Chief Financial Officer Camden National Corporation (800) 860-8821 marcher@CamdenNational.

April 4, 2025 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, For Use of the Commission Only ý Definitive Proxy Statement o Definitive Additional Materi

March 27, 2025 EX-24.1

Power of attorney.

Exhibit 24.1 POWER OF ATTORNEY Each person whose signature appears below constitutes and appoints each of Simon R. Griffiths and Michael R. Archer, with full power to act without the other, his or her true and lawful attorney-in-fact and agent, with full and several power of substitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any or all amendmen

March 27, 2025 RW

CAMDEN NATIONAL CORPORATION 2 Elm Street Camden, Maine 04843 March 27, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Re: Camden National Corporation Withdrawal of Form S-3, Fil

camden-sx3withdrawalrequ CAMDEN NATIONAL CORPORATION 2 Elm Street Camden, Maine 04843 March 27, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Re: Camden National Corporation Withdrawal of Form S-3, File No.

March 27, 2025 S-3ASR

As filed with the Securities and Exchange Commission on March 26, 2025

As filed with the Securities and Exchange Commission on March 26, 2025 Registration No.

March 27, 2025 EX-FILING FEES

Filing Fee Exhibit.

Exhibit 107 Form S-3 (Form Type) Camden National Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carr

March 26, 2025 EX-24.1

Power of attorney.

Exhibit 24.1 POWER OF ATTORNEY Each person whose signature appears below constitutes and appoints each of Simon R. Griffiths and Michael R. Archer, with full power to act without the other, his or her true and lawful attorney-in-fact and agent, with full and several power of substitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any or all amendmen

March 26, 2025 EX-FILING FEES

Filing Fee Exhibit.

Exhibit 107 Form S-3 (Form Type) Camden National Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carr

March 26, 2025 S-3

As filed with the Securities and Exchange Commission on March 26, 2025

As filed with the Securities and Exchange Commission on March 26, 2025 Registration No.

March 25, 2025 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 25, 2025 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 001-13227 01-0413282 (State or other jurisdiction of incorporation) (Commission

March 25, 2025 EX-99.1

Camden National Corporation Announces its First Quarter 2025 Dividend

CONTACT: Michael Archer Executive Vice President Chief Financial Officer Camden National Corporation (800) 860-8821 marcher@camdennational.

March 11, 2025 8-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 2, 2025 Camden National

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 2, 2025 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 001-13227 01-0413282 (State or other jurisdiction of incorporation) (Commiss

March 11, 2025 EX-99.2

Unaudited Pro Forma Condensed Combined Financial Data

Unaudited Pro Forma Condensed Combined Financial Data The following unaudited pro forma condensed combined financial data is based on the historical financial data of Camden National Corporation (“Camden”) and Northway Financial, Inc.

March 11, 2025 EX-99.1

4 INDEPENDENT AUDITORS’ REPORT Audit Committee of Camden National Corporation Report on the Audit of the Financial Statements Opinion We have audited the consolidated financial statements of Northway Financial, Inc. and Subsidiary (the Company), whic

4 INDEPENDENT AUDITORS’ REPORT Audit Committee of Camden National Corporation Report on the Audit of the Financial Statements Opinion We have audited the consolidated financial statements of Northway Financial, Inc.

March 7, 2025 EX-19.1

Camden National Corporation

CAMDEN NATIONAL CORPORATION INSIDER TRADING POLICY This document (the “Insider Trading Policy”) sets forth the policy of Camden National Corporation and its subsidiaries (together, the “Company”) regarding insider trading or tipping.

March 7, 2025 EX-21.1

Subsidiaries of the Company.

Exhibit 21.1 Camden National Bank, a national banking organization organized under the laws of the United States of America. Healthcare Professional Funding Corporation, a wholly-owned subsidiary of Camden National Bank Property A, a wholly-owned subsidiary of Camden National Bank

March 7, 2025 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 001-13227 CAMDEN NATIONAL CORPORATION (Exact Name of Registrant As Specified

February 26, 2025 EX-99.1

Camden National Corp. Appoints Raina Maxwell to Board of Directors Board welcomes customer experience and financial leader to drive innovation and growth

FOR IMMEDIATE RELEASE Media Inquiries: Renée Smyth Chief Experience and Marketing Officer (207) 518-5607 rsmyth@CamdenNational.

February 26, 2025 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 25, 2025 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 001-13227 01-0413282 (State or other jurisdiction of incorporation) (Commiss

January 29, 2025 EX-99.1

1 2 Forward-Looking Statements and Non-GAAP Financial Measures This presentation may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including certain plans, expectations, g

1 2 Forward-Looking Statements and Non-GAAP Financial Measures This presentation may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including certain plans, expectations, goals, projections, and other statements, which are subject to numerous risks, assumptions, and uncertainties.

January 29, 2025 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 29, 2025 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 001-13227 01-0413282 (State or other jurisdiction of incorporation) (Commissi

January 28, 2025 EX-99.1

CAMDEN NATIONAL CORPORATION REPORTS FOURTH QUARTER AND YEAR END 2024 FINANCIAL RESULTS Fourth Quarter Net Interest Margin Expansion and Solid Earnings Set the Stage Heading Into 2025

CONTACT: Michael Archer Executive Vice President Chief Financial Officer Camden National Corporation (800) 860-8821 marcher@camdennational.

January 28, 2025 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 28, 2025 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 001-13227 01-0413282 (State or other jurisdiction of incorporation) (Commissi

January 2, 2025 8-K

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 1, 2025 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 001-13227 01-0413282 (State or other jurisdiction of incorporation) (Commissio

January 2, 2025 EX-99.1

Camden National Corp. Announces Successful Merger with Northway Financial Appoints Larry Haynes to Board of Directors

FOR IMMEDIATE RELEASE Media Inquiries: Renée Smyth Chief Experience and Marketing Officer (207) 518-5607 rsmyth@CamdenNational.

December 20, 2024 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 20, 2024 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 001-13227 01-0413282 (State or other jurisdiction of incorporation) (Commiss

December 20, 2024 EX-99.1

Camden National Corp. Receives Regulatory Approvals for Merger of Northway Financial, Inc.

FOR IMMEDIATE RELEASE Media Inquiries: Renée Smyth Chief Experience and Marketing Officer (207) 518-5607 rsmyth@CamdenNational.

December 17, 2024 EX-99.1

Camden National Corporation Announces its Fourth Quarter 2024 Dividend

CONTACT: Michael Archer Executive Vice President Chief Financial Officer Camden National Corporation (800) 860-8821 marcher@camdennational.

December 17, 2024 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 17, 2024 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 001-13227 01-0413282 (State or other jurisdiction of incorporation) (Commiss

December 2, 2024 EX-99.1

Simon Griffiths President and CEO • Served as head of core banking at Citizens Bank • Joined 2023 • 27+ years of industry experience Trish Rose EVP, Retail & Mortgage Banking • 25+ years of industry experience Barbara Raths EVP, Commercial Banking •

Simon Griffiths President and CEO • Served as head of core banking at Citizens Bank • Joined 2023 • 27+ years of industry experience Trish Rose EVP, Retail & Mortgage Banking • 25+ years of industry experience Barbara Raths EVP, Commercial Banking • 18+ years of industry experience Mike Archer EVP, CFO • 10+ years of industry experience Garrett McKnight EVP, Managing Director, Camden National Weal

December 2, 2024 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 2, 2024 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 001-13227 01-0413282 (State or other jurisdiction of incorporation) (Commissi

December 2, 2024 425

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 2, 2024 Camden National

form425investorpresentat UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

November 7, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 001-13227 CAMDEN NATIONAL CORPORATION (Exact name of registrant

November 4, 2024 424B3

Proxy Statement/Prospectus Merger Proposal—Your Vote Is Important

TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(3) Registration No. 333-282728   Proxy Statement/Prospectus Merger Proposal—Your Vote Is Important On September 9, 2024, Camden National Corporation, which we refer to as Camden, and Northway Financial, Inc., which we refer to as Northway, entered into an Agreement and Plan of Merger, which we refer to as the merger agreement, pursuant to which Camde

October 31, 2024 S-4/A

As filed with the Securities and Exchange Commission on October 31, 2024

TABLE OF CONTENTS As filed with the Securities and Exchange Commission on October 31, 2024 Registration No.

October 31, 2024 EX-99.1

EX-99.1

Exhibit 99.1

October 31, 2024 CORRESP

Camden National Corporation 2 Elm Street Camden, Maine 04843

Camden National Corporation 2 Elm Street Camden, Maine 04843 October 31, 2024 Via EDGAR United States Securities and Exchange Commission, Division of Corporation Finance, 100 F Street, N.

October 31, 2024 EX-99.2

Consent of Performance Trust Capital Partners, LLC

Exhibit 99.2 October 31, 2024 Consent of Performance Trust Capital Partners, LLC We hereby consent to the inclusion of our opinion letter to the Board of Directors of Northway Financial, Inc. (the “Company”) as an Appendix to the Proxy Statement/Prospectus relating to the proposed merger of the Company with and into Camden National Corporation contained in Amendment No. 1 to the Registration State

October 30, 2024 425

Filed by: Camden National Corporation

Filed by: Camden National Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Northway Financial, Inc.

October 29, 2024 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 29, 2024 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commissio

October 29, 2024 EX-99.1

Camden National Corporation Reports Third Quarter 2024 Earnings of $13.1 Million and Diluted EPS of $0.90 Net Interest Margin Expansion and Robust Asset Quality Drive a Strong Quarter

CONTACT: Michael Archer Executive Vice President Chief Financial Officer Camden National Corporation (800) 860-8821 marcher@CamdenNational.

October 29, 2024 425

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 29, 2024 Camden National

form425102924-2024x10x29 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

October 18, 2024 EX-99.2

Consent of Performance Trust Capital Partners, LLC

Exhibit 99.2 October 18, 2024 Consent of Performance Trust Capital Partners, LLC We hereby consent to the inclusion of our opinion letter to the Board of Directors of Northway Financial, Inc. (the “Company”) as an Appendix to the Proxy Statement/Prospectus relating to the proposed merger of the Company with and into Camden National Corporation contained in the Registration Statement on Form S-4 (t

October 18, 2024 S-4

As filed with the Securities and Exchange Commission on October 18, 2024

TABLE OF CONTENTS As filed with the Securities and Exchange Commission on October 18, 2024 Registration No.

October 18, 2024 EX-99.3

CONSENT OF PROSPECTIVE DIRECTOR

Exhibit 99.3 CONSENT OF PROSPECTIVE DIRECTOR In accordance with Rule 438 promulgated under the Securities Act of 1933, as amended, I hereby consent to my being named in this Registration Statement on Form S-4, to which this consent is an exhibit, filed by Camden National Corporation (the “Registrant”) with the Securities and Exchange Commission, and all amendments (including post-effective amendme

October 18, 2024 EX-FILING FEES

Calculation of Filing Fee Tables Form S-4 (Form Type) CAMDEN NATIONAL CORPORATION (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities

Exhibit 107 Calculation of Filing Fee Tables Form S-4 (Form Type) CAMDEN NATIONAL CORPORATION (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Proposed Maximum Aggregate Offering Price Fee Rate(3) Amount of Registration Fee Newly Registered Securities Fees to Be Paid Equity Common stock, no par value per share (1) Other (2) 2,283,869 (1) - $ 84,778,337 (2) 0.

October 3, 2024 425

Filed by: Camden National Corporation

Filed by: Camden National Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Northway Financial, Inc.

October 1, 2024 425

Filed by: Camden National Corporation

Filed by: Camden National Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Northway Financial, Inc.

September 24, 2024 EX-99.1

Camden National Corporation Announces its Third Quarter 2024 Dividend

CONTACT: Michael Archer Executive Vice President Chief Financial Officer Camden National Corporation (800) 860-8821 marcher@camdennational.

September 24, 2024 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 24, 2024 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 001-13227 01-0413282 (State or other jurisdiction of incorporation) (Commis

September 10, 2024 425

Filed by: Camden National Corporation

Filed by: Camden National Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Northway Financial, Inc.

September 10, 2024 425

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 9, 2024 Camden National

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 9, 2024 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 001-13227 01-0413282 (State or other jurisdiction of incorporation) (Commiss

September 10, 2024 425

Filed by: Camden National Corporation

Filed by: Camden National Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Northway Financial, Inc.

September 10, 2024 EX-2.1

Agreement and Plan of Merger dated as of September 9, 2024, by and between Camden National Corporation and Northway Financial, Inc. (incorporated herein by reference to Exhibit 2.1 to the Company’s Form 8-K filed with the Commission on September 10, 2024).

Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among CAMDEN NATIONAL CORPORATION and NORTHWAY FINANCIAL, INC. Dated as of September 9, 2024 TABLE OF CONTENTS Page ARTICLE I - THE MERGERS 1 1.1 The Merger 1 1.2 Effective Time 2 1.3 Effects of the Merger 2 1.4 Closing 2 1.5 Articles of Incorporation and Bylaws 2 1.6 Directors of the Surviving Corporation 2 1.7 Officers of the Surviving Corporation

September 10, 2024 425

1

Table of Contents Filed by: Camden National Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Northway Financial, Inc.

September 10, 2024 425

Filed by: Camden National Corporation

Filed by: Camden National Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Northway Financial, Inc.

September 10, 2024 EX-99.2

Forward-Looking Statements and Non-GAAP Financial Measures Forward-Looking Statements This presentation may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements about Camden’s

Exhibit 99.2 1 1 1 Forward-Looking Statements and Non-GAAP Financial Measures Forward-Looking Statements This presentation may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements about Camden’s beliefs, plans, strategies, predictions, forecasts, objectives, intentions, assumptions or expectations are not historical facts a

September 10, 2024 425

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 9, 2024 Camden National

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 9, 2024 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 001-13227 01-0413282 (State or other jurisdiction of incorporation) (Commiss

September 10, 2024 8-K

Regulation FD Disclosure, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 9, 2024 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 001-13227 01-0413282 (State or other jurisdiction of incorporation) (Commiss

September 10, 2024 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 9, 2024 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 001-13227 01-0413282 (State or other jurisdiction of incorporation) (Commiss

September 10, 2024 EX-99.1

Camden National Corporation and Northway Financial, Inc. to Merge Positions Camden National as a Premier Northern New England Bank

Exhibit 99.1 FOR IMMEDIATE RELEASE Media Inquiries: For Camden National Corporation: Renée Smyth Chief Experience and Marketing Officer (207) 518-5607 [email protected] For Northway Financial, Inc.: Gary Laurash Chief Financial Officer (603) 326-7377 [email protected] Camden National Corporation and Northway Financial, Inc. to Merge Positions Camden National as a Premier Northern

August 8, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 0-28190 CAMDEN NATIONAL CORPORATION (Exact name of registrant as spec

July 30, 2024 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 30, 2024 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission F

July 30, 2024 EX-99.1

Camden National Corporation Reports Second Quarter 2024 Earnings of $12.0 Million and Diluted EPS of $0.81 Net Interest Margin Expands, Asset Quality Remains Strong

CONTACT: Michael Archer Executive Vice President Chief Financial Officer Camden National Corporation (800) 860-8821 marcher@camdennational.

June 25, 2024 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 25, 2024 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission F

June 25, 2024 EX-99.1

Camden National Corporation Announces its Second Quarter 2024 Dividend

CONTACT: Michael Archer Executive Vice President Chief Financial Officer Camden National Corporation (800) 860-8821 marcher@camdennational.

June 20, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 20, 2024 Camden National Cor

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 20, 2024 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission F

June 20, 2024 EX-99.1

1 1 2 Forward-Looking Statements and Non-GAAP Financial Measures 2 Forward-Looking Statements. This presentation contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal

ex991investorpresentatio 1 1 2 Forward-Looking Statements and Non-GAAP Financial Measures 2 Forward-Looking Statements.

May 22, 2024 8-K

Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 21, 2024 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission Fi

May 8, 2024 EX-10.1

gory A. Dufour, pursuant to the Transition Employment and Retention Agreement between Gregory A. Dufour, Camden National Corporation and Camden National Bank dated August 16, 2023.

EXECUTION VERSION GENERAL RELEASE AND WAIVER OF CLAIMS (this “Release”), by Gregory A.

May 8, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 0-28190 CAMDEN NATIONAL CORPORATION (Exact name of registrant as spe

April 30, 2024 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 30, 2024 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission

April 30, 2024 EX-99.1

Camden National Corporation Reports First Quarter 2024 Earnings of $13.3 Million and Diluted EPS of $0.91 Asset Quality, Capital and Liquidity Remain Strong

CONTACT: Michael Archer Executive Vice President Chief Financial Officer Camden National Corporation (800) 860-8821 marcher@camdennational.

April 9, 2024 EX-10.1

Camden National Corporation Executive Annual Incentive Program, as amended and restated, effective January 1, 2024.

4884-0379-2537 v.6 I.Executive Annual Incentive Program A.Introduction and Objective Camden National Bank and Camden National Corporation (collectively, the “Company”) are committed to rewarding employees for their contributions to the Company’s success. The Executive Annual Incentive Program (the “EAIP” or “Program”) is part of a total compensation package which includes base salary, annual incen

April 9, 2024 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 3, 2024 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission F

April 5, 2024 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, For Use of the Commission Only ý Definitive Proxy Statement o Definitive Additional Materi

March 26, 2024 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 26, 2024 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission

March 26, 2024 EX-99.1

Camden National Corporation Announces its First Quarter 2024 Dividend

CONTACT: Michael Archer Executive Vice President Chief Financial Officer Camden National Corporation (800) 860-8821 marcher@camdennational.

March 8, 2024 EX-21.1

Subsidiaries of the Company.

Exhibit 21.1 Camden National Bank, a national banking organization organized under the laws of the United States of America. Healthcare Professional Funding Corporation, a wholly-owned subsidiary of Camden National Bank Property A, a wholly-owned subsidiary of Camden National Bank

March 8, 2024 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 6, 2024 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission F

March 8, 2024 EX-10.31

Letter Agreement between Timothy P. Nightingale, Camden National Bank and C

EXECUTION VERSION December 12, 2023 Mr. Timothy P. Nightingale Dear Tim: As discussed, your employment with Camden National Bank and Camden National Corporation (the “Company”) will terminate on December 12, 2023 (the “Separation Date”) due to your retirement for personal health reasons. This letter (this “Letter Agreement”) is being provided to you to describe amounts and the conditions on which

March 8, 2024 EX-97

Camden National Corporation Incentive-Based Compensation Recovery Policy dated December 1, 2023

CAMDEN NATIONAL CORPORATION CLAWBACK POLICY I. BACKGROUND Camden National Corporation (the “Company”) has adopted this policy (this “Policy”) to provide for the recovery or “clawback” of certain incentive compensation in the event of a Restatement. This Policy is intended to comply with, and will be interpreted to be consistent with, the requirements of the Nasdaq Stock Market (“Nasdaq”) Listing R

March 8, 2024 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 0-28190 CAMDEN NATIONAL CORPORATION (Exact Name of Registrant As Specified i

February 13, 2024 SC 13G/A

CAC / Camden National Corporation / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)* Name of issuer: Camden National Corp Title of Class of Securities: Common Stock CUSIP Number: 133034108 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

February 9, 2024 SC 13G/A

CAC / Camden National Corporation / DIMENSIONAL FUND ADVISORS LP - SEC SCHEDULE 13G Passive Investment

SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5 )* Camden National Corp (Name of Issuer) Common Stock (Title of Class of Securities) 133034108 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box t

January 30, 2024 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 30, 2024 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commissio

January 30, 2024 EX-99.1

CAMDEN NATIONAL CORPORATION REPORTS FOURTH QUARTER AND YEAR END 2023 FINANCIAL RESULTS Reports Fourth Quarter 2023 Net Income of $8.5 million and Diluted EPS of $0.58; Capital and Asset Quality Remain Strong at Year End

CONTACT: Michael Archer Executive Vice President Chief Financial Officer Camden National Corporation (800) 860-8821 marcher@camdennational.

January 30, 2024 SC 13G/A

CAC / Camden National Corporation / FRANKLIN MUTUAL ADVISERS LLC Passive Investment

camd23a1.htm - Generated by SEC Publisher for SEC Filing CUSIP NO. 133034108 13G Page 1 of 8 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* CAMDEN NATIONAL CORPORATION (Name of Issuer) Common Stock, without par value (Title of Class of Securities) 133034108 (CUSIP Number) December 31, 2023 (Date of E

January 5, 2024 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 4, 2024 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission

December 19, 2023 EX-99.1

Camden National Corporation Announces its Fourth Quarter 2023 Dividend

CONTACT: Michael Archer Executive Vice President Chief Financial Officer Camden National Corporation (800) 860-8821 marcher@camdennational.

December 19, 2023 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 19, 2023 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commissi

December 14, 2023 8-K

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 12, 2023 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commissi

December 14, 2023 EX-99.1

Camden National Bank Names New Chief Credit Officer

FOR IMMEDIATE RELEASE: MEDIA CONTACT: Renée Smyth, Executive Vice President Chief Experience & Marketing Officer (800) 860-8821 rsmyth@CamdenNational.

November 7, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 0-28190 CAMDEN NATIONAL CORPORATION (Exact name of registrant as

November 7, 2023 EX-10.1

Transition Employment and Retention Agreement between Gregory A. Dufour, Camden National Corporation and Camden National Bank dated August 16, 2023 (incorporated herein by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q filed with the Commission on November 7, 2023).

Execution Version TRANSITION EMPLOYMENT AND RETENTION AGREEMENT THIS AGREEMENT is made and entered into on this 16th day of August, 2023, by and between CAMDEN NATIONAL BANK and CAMDEN NATIONAL CORPORATION (together, “CNB”) and GREGORY A.

November 7, 2023 EX-10.2

Letter Agreement between Simon Griffiths, Camden National Bank and Camden National Corporation, dated August 14, 2023 (incorporated herein by reference to Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q filed with the Commission on November 7, 2023).

CONFIDENTIAL August 14, 2023 Simon Griffiths Address Dear Simon, It is with great pleasure I provide this letter (this “Letter”) to you formally summarizing the terms of your offer of employment with Camden National Bank and Camden National Corporation (the “Company”).

October 31, 2023 EX-99.1

CAMDEN NATIONAL CORPORATION REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS Reports Third Quarter 2023 Net Income of $9.8 million and Diluted EPS of $0.67

CONTACT: Michael Archer Executive Vice President Chief Financial Officer Camden National Corporation (800) 860-8821 marcher@camdennational.

October 31, 2023 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 31, 2023 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commissio

September 26, 2023 EX-99.1

Camden National Corporation Announces its Third Quarter 2023 Dividend

CONTACT: Michael Archer Executive Vice President Chief Financial Officer Camden National Corporation (800) 860-8821 marcher@camdennational.

September 26, 2023 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 26, 2023 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commiss

September 6, 2023 EX-99.1

1 Investor Presentation Greg Dufour | President & Chief Executive Officer Mike Archer | EVP, Chief Financial Officer September 6, 2023 1 2 Forward Looking Statements 2 This presentation contains certain forward-looking statements within the meaning o

1 Investor Presentation Greg Dufour | President & Chief Executive Officer Mike Archer | EVP, Chief Financial Officer September 6, 2023 1 2 Forward Looking Statements 2 This presentation contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws, including certain plans, exceptions, goals, projections, and statements, which are subject to numerous risks, assumptions, and uncertainties.

September 6, 2023 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 6, 2023 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commissi

August 21, 2023 EX-99.1

Camden National Corporation Appoints Simon Griffiths as Successor to CEO Griffiths to take helm at yearend as Greg Dufour retires after nearly two decades as President and CEO

FOR IMMEDIATE RELEASE: MEDIA CONTACT: Renée Smyth Chief Experience & Marketing Officer (800) 860-8821 rsmyth@CamdenNational.

August 21, 2023 8-K

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 16, 2023 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission

August 9, 2023 EX-10.2

Form of Restricted Stock Award Agreement Under the Camden National Corporation 2022 Equity and Incentive Plan (incorporated herein by reference to Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q filed with the Commission on August 9, 2023).

RESTRICTED STOCK AWARD AGREEMENT UNDER THE CAMDEN NATIONAL CORPORATION 2022 EQUITY AND INCENTIVE PLAN Name of Grantee: No.

August 9, 2023 EX-10.1

Form of Performance Share Unit Award Agreement Under the Camden National Corporation Third Amended and Restated Long-Term Incentive Program. (incorporated herein by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q filed with the Commission on August 9, 2023).

PERFORMANCE SHARE UNIT AWARD AGREEMENT UNDER THE CAMDEN NATIONAL CORPORATION THIRD AMENDED AND RESTATED LONG-TERM INCENTIVE PROGRAM Name of Grantee: No.

August 9, 2023 EX-4.1

Description of Camden National Corporation's Securities Registered under Section 12 of the Exchange Act.

Exhibit 4.1 DESCRIPTION OF CAPITAL STOCK A brief summary of the material terms of our capital stock is set forth below. The description is qualified in its entirety by reference to our Articles of Incorporation, as amended (the “Articles”) and Amended and Restated Bylaws (the “Bylaws”) that are filed as exhibits to the Form 10-K of which this Exhibit is a part. The following description of our cap

August 9, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 0-28190 CAMDEN NATIONAL CORPORATION (Exact name of registrant as spec

August 8, 2023 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 8, 2023 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission

August 8, 2023 EX-99.1

• • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • 77% 82% 85% 83% 87%88% 28% 25% 23% 22% 21%22% -1.00% 1.00% 3.00% 5.00% 7.00% 9

• • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • 77% 82% 85% 83% 87%88% 28% 25% 23% 22% 21%22% -1.

July 25, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 25, 2023 Camden National Cor

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 25, 2023 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission F

July 25, 2023 EX-99.2

1 Q2 2023 Earnings Release Supplement July 25, 2023 2 Forward Looking Statements This presentation contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities law

ex992q2earningssupplemen 1 Q2 2023 Earnings Release Supplement July 25, 2023 2 Forward Looking Statements This presentation contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws, including certain plans, exceptions, goals, projections, and statements, which are subject to numerous risks, assumptions, and uncertainties.

July 25, 2023 EX-99.1

CAMDEN NATIONAL CORPORATION REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS Balance Sheet and Asset Quality Remain Strong

CONTACT: Michael Archer Executive Vice President Chief Financial Officer Camden National Corporation (800) 860-8821 marcher@camdennational.

June 27, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 27, 2023 Camden National Cor

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 27, 2023 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission F

June 27, 2023 EX-99.1

Camden National Corporation Announces its Second Quarter 2023 Dividend

CONTACT: Michael Archer Executive Vice President Chief Financial Officer Camden National Corporation (800) 860-8821 marcher@camdennational.

June 22, 2023 EX-99.1

• • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • - 500,000 1,000,000 1,500,000 2,000,000 2,500,000 3,000,000 3,500,000 4,000,000 4,500,000 0.00% 1.00% 2.00% 3.00% 4.00

ex991investorpresentatio • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • - 500,000 1,000,000 1,500,000 2,000,000 2,500,000 3,000,000 3,500,000 4,000,000 4,500,000 0.

June 22, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 22, 2023 Camden National Cor

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 22, 2023 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission F

May 25, 2023 EX-3.2

Amended and Restated Bylaws of Camden National Corporation (filed as Exhibit 3.2 to Camden National Corporation’s Current Report on Form 8-K (File No. 001-13227) filed on May 25, 2023 and incorporated herein by reference).

CAMDEN NATIONAL CORPORATION AMENDED AND RESTATED BYLAWS ARTICLE I General Section 1.

May 25, 2023 EX-3.1

Amended and Restated Articles of Incorporation of Camden National Corporation (filed as Exhibit 3.1 to Camden National Corporation’s Current Report on Form 8-K (File No. 001-13227) filed on May 25, 2023 and incorporated herein by reference).

Deputy Secretary of State A True Copy When Attested By Signature Deputy Secretary of State Filing Fee $80.

May 25, 2023 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 23, 2023 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission Fi

May 23, 2023 EX-99.1

• • • • • • Presenters: Larry Sterrs Director and Chair of the Board of Directors Mike Archer Chief Financial Officer Greg Dufour President and Chief Executive Officer Recording Secretary: Joanne Campbell Executive Vice President, Enterprise Risk Man

ex9912023presentation • • • • • • Presenters: Larry Sterrs Director and Chair of the Board of Directors Mike Archer Chief Financial Officer Greg Dufour President and Chief Executive Officer Recording Secretary: Joanne Campbell Executive Vice President, Enterprise Risk Management and Chief Risk Officer Inspector of Election: Brandon Boey Senior Vice President, Legal Affairs and BSA Officer • • • • • • • • -100% -50% 0% 50% 100% 150% 200% 250% 300% 5/11/2008 5/11/2009 5/11/2010 5/11/2011 5/11/2012 5/11/2013 5/11/2014 5/11/2015 5/11/2016 5/11/2017 5/11/2018 5/11/2019 5/11/2020 5/11/2021 5/11/2022 5/11/2023 CAC S&P SmallCap Banks S&P U.

May 23, 2023 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 23, 2023 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission Fi

May 9, 2023 EX-10.1

Camden National Corporation Third Amended and Restated Long-Term Incentive Program, effective as of March 31, 2023 (incorporated herein by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q filed with the Commission on May 9, 2023).

CAMDEN NATIONAL CORPORATION THIRD AMENDED AND RESTATED LONG-TERM INCENTIVE PROGRAM Effective March 31, 2023 1.

May 9, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 0-28190 CAMDEN NATIONAL CORPORATION (Exact name of registrant as spe

May 9, 2023 EX-10.3

Camden National Corporation Third Amended and Restated Defined Contribution Retirement Program, effective as of April 26, 2023 (incorporated herein by reference to Exhibit 10.3 to the Company's Quarterly Report on Form 10-Q filed with the Commission on May 9, 2023).

CAMDEN NATIONAL CORPORATION THIRD AMENDED AND RESTATED DEFINED CONTRIBUTION RETIREMENT PROGRAM Effective April 26, 2023 This Camden National Corporation Third Amended and Restated Defined Contribution Retirement Program (the “Program”), effective as of April 26, 2023 is an amendment and restatement of the Camden National Corporation Second Amended and Restated Defined Contribution Retirement Plan, effective as of January 30, 2018.

April 25, 2023 EX-99.1

CAMDEN NATIONAL CORPORATION REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS Capital, Liquidity and Asset Quality Remain Strong

CONTACT: Michael Archer Executive Vice President Chief Financial Officer Camden National Corporation (800) 860-8821 marcher@camdennational.

April 25, 2023 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 25, 2023 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission

April 25, 2023 EX-99.2

Total primary liquidity is 1.9x uninsured and uncollateralized deposits Customers with <$1mm in balances made up 65% of adjusted total deposits(3) at 3/31/23 and 63% at 12/31/22 • • • • • • • • • • • • (In thousands) March 31, 2023 December 31, 2022

ex992q1earningssupplemen Total primary liquidity is 1.9x uninsured and uncollateralized deposits Customers with <$1mm in balances made up 65% of adjusted total deposits(3) at 3/31/23 and 63% at 12/31/22 • • • • • • • • • • • • (In thousands) March 31, 2023 December 31, 2022 Total deposits, as presented 4,642,734$ 4,826,929$ Add: Customer repurchase agreements 196,918 196,451 Less: Brokered deposit

April 25, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 25, 2023 Camden National Co

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 25, 2023 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission

April 11, 2023 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, For Use of the Commission Only ý Definitive Proxy Statement o Definitive Additional Materi

March 31, 2023 PRE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: ý Preliminary Proxy Statement o Confidential, For Use of the Commission Only o Definitive Proxy Statement o Definitive Additional Materi

March 29, 2023 EX-99.1

Camden National Corporation Announces Enhancements to Corporate Governance

CONTACT: Renée Smyth Executive Vice President Chief Experience & Marketing Officer Camden National Corporation (800) 860-8821 rsmyth@camdennational.

March 29, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 29, 2023 Camden National Co

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 29, 2023 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission

March 28, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 28, 2023 Camden National Co

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 28, 2023 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission

March 28, 2023 EX-99.1

Camden National Corporation Announces its First Quarter 2023 Dividend

CONTACT: Michael Archer Executive Vice President Chief Financial Officer Camden National Corporation (800) 860-8821 marcher@camdennational.

March 13, 2023 EX-99.1

1 Investor Presentation Gregory Dufour | President & Chief Executive Officer Michael Archer | EVP, Chief Financial Officer March 13, 2023 2 Forward Looking Statements This presentation contains certain forward-looking statements within the meaning of

ex991ip031323 1 Investor Presentation Gregory Dufour | President & Chief Executive Officer Michael Archer | EVP, Chief Financial Officer March 13, 2023 2 Forward Looking Statements This presentation contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws, including certain plans, exceptions, goals, projections, and statements, which are subject to numerous risks, assumptions, and uncertainties.

March 13, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 13, 2023 Camden National Co

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 13, 2023 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission

March 10, 2023 EX-10.25

Form of Restricted Stock Unit Award Agreement for Company Employees Under the 2022 Equity and Incentive Plan, effective as of February 28, 2023 (incorporated herein by reference to Exhibit 10.25 to the Company’s Form 10-K filed with the commission on March 10, 2023).

RESTRICTED STOCK UNIT AWARD AGREEMENT FOR COMPANY EMPLOYEES UNDER THE CAMDEN NATIONAL CORPORATION 2022 EQUITY AND INCENTIVE PLAN Name of Grantee: [GRANTEE NAME] No.

March 10, 2023 EX-21.1

Subsidiaries of the Company.

Exhibit 21.1 Camden National Bank, a national banking organization organized under the laws of the United States of America. Healthcare Professional Funding Corporation, a wholly-owned subsidiary of Camden National Bank Property A, a wholly-owned subsidiary of Camden National Bank

March 10, 2023 EX-10.24

Form of Restricted Stock Award Agreement Under the Third Amended and Restated Management Stock Purchase Program (incorporated herein by reference to Exhibit 10.24 to the Company’s Form 10-K filed with the commission on March 10, 2023).

RESTRICTED STOCK AWARD AGREEMENT UNDER THE CAMDEN NATIONAL CORPORATION THIRD AMENDED AND RESTATED MANAGEMENT STOCK PURCHASE PROGRAM Name of Grantee: No.

March 10, 2023 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 0-28190 CAMDEN NATIONAL CORPORATION (Exact Name of Registrant As Specified i

March 10, 2023 EX-10.23

Camden National Corporation Third Amended and Restated Management Stock Purchase Program, effective as of February 28, 2023 (incorporated herein by reference to Exhibit 10.23 to the Company's Form 10-K filed with the commission on March 10, 2023).

CAMDEN NATIONAL CORPORATION THIRD AMENDED AND RESTATED MANAGEMENT STOCK PURCHASE PROGRAM Effective February 28, 2023 I.

March 10, 2023 EX-4.1

Description of Camden National Corporation's Securities Registered under Section 12 of the Exchange Act.

Exhibit 4.1 DESCRIPTION OF CAPITAL STOCK A brief summary of the material terms of our capital stock is set forth below. The description is qualified in its entirety by reference to our Articles of Incorporation, as amended (the “Articles”) and Amended and Restated Bylaws (the “Bylaws”) that are filed as exhibits to the Form 10-K of which this Exhibit is a part. The following description of our cap

February 10, 2023 SC 13G/A

CAC / Camden National Corporation / DIMENSIONAL FUND ADVISORS LP - SEC SCHEDULE 13G Passive Investment

SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4 )* Camden National Corp (Name of Issuer) Common Stock (Title of Class of Securities) 133034108 (CUSIP Number) December 30, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box t

February 9, 2023 SC 13G

CAC / Camden National Corporation / VANGUARD GROUP INC - SCHEDULE 13G Passive Investment

SC 13G 1 tv0498-camdennationalcorp.htm SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Name of issuer: Camden National Corp. Title of Class of Securities: Common Stock CUSIP Number: 133034108 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant

January 31, 2023 EX-99.1

CAMDEN NATIONAL CORPORATION REPORTS FOURTH QUARTER AND YEAR END 2022 FINANCIAL RESULTS Camden National Corporation Reports an 8% Increase in Fourth Quarter 2022 Net Income over Third Quarter 2022

CONTACT: Michael Archer Executive Vice President Chief Financial Officer Camden National Corporation (800) 860-8821 marcher@camdennational.

January 31, 2023 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 31, 2023 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commissio

January 30, 2023 SC 13G

CAC / Camden National Corporation / FRANKLIN MUTUAL ADVISERS LLC Passive Investment

SC 13G 1 camd22in.htm CUSIP NO. 133034108 13G Page 1 of 7 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* CAMDEN NATIONAL CORPORATION (Name of Issuer) Common Stock, without par value (Title of Class of Securities) 133034108 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this S

January 3, 2023 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 29, 2022 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commissi

December 22, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 20, 2022 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commissi

December 22, 2022 EX-99.1

Camden National Corporation Appoints Robert Merrill to Board of Directors

FOR IMMEDIATE RELEASE CONTACT: Katie Krott Public Relations & Communications Specialist Camden National Bank kkrott@CamdenNational.

December 20, 2022 EX-99.1

Camden National Corporation Announces a 5% Increase in its Fourth Quarter 2022 Dividend

CONTACT: Michael Archer Executive Vice President Chief Financial Officer Camden National Corporation (800) 860-8821 marcher@camdennational.

December 20, 2022 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 20, 2022 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commissi

November 3, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 0-28190 CAMDEN NATIONAL CORPORATION (Exact name of registrant as

October 25, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 25, 2022 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commissio

October 25, 2022 EX-99.1

CAMDEN NATIONAL CORPORATION REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS Camden National Corporation Reports Net Income of $14.3 Million for the Third Quarter of 2022 and $46.1 Million for the Nine Months Ended September 30, 2022

CONTACT: Michael Archer Executive Vice President Chief Financial Officer Camden National Corporation (800) 860-8821 marcher@camdennational.

September 28, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 27, 2022 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commiss

September 28, 2022 EX-99.1

Camden National Corporation Appoints Rebecca Hatfield to Board of Directors Bank welcomes distinguished credit risk and housing leader

CONTACT: Ren?e Smyth Chief Experience & Marketing Officer Camden National Bank (207) 518-5607 or rsmyth@CamdenNational.

September 27, 2022 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 27, 2022 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commiss

September 27, 2022 EX-99.1

Camden National Corporation Announces its Third Quarter 2022 Dividend

CONTACT: Michael Archer Executive Vice President Chief Financial Officer Camden National Corporation (800) 860-8821 marcher@camdennational.

September 7, 2022 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 7, 2022 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commissi

September 7, 2022 EX-99.1

• • • • • • • • • o o o o • • • • • • • • • • • • • Acquisitions: 2008 Union Bankshares 2012 Bank of America (14 branches) 2015 The Bank of Maine as of 12/31/21 3 Year 5 Year 10 Year Total Return 47.7% 25.2% 195.8% TBV/Sh CAGR 11.7% 10.0% 7.2% EPS CA

? ? ? ? ? ? ? ? ? o o o o ? ? ? ? ? ? ? ? ? ? ? ? ? Acquisitions: 2008 Union Bankshares 2012 Bank of America (14 branches) 2015 The Bank of Maine as of 12/31/21 3 Year 5 Year 10 Year Total Return 47.

August 4, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 0-28190 CAMDEN NATIONAL CORPORATION (Exact name of registrant as spec

August 2, 2022 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 2, 2022 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission

August 2, 2022 EX-99.1

• • • • • • • • • o o o o • • • • • • • • • • • • • Acquisitions: 2008 Union Bankshares 2012 Bank of America (14 branches) 2015 The Bank of Maine as of 12/31/21 3 Year 5 Year 10 Year Total Return 47.7% 25.2% 195.8% TBV/Sh CAGR 11.7% 10.0% 7.2% EPS CA

? ? ? ? ? ? ? ? ? o o o o ? ? ? ? ? ? ? ? ? ? ? ? ? Acquisitions: 2008 Union Bankshares 2012 Bank of America (14 branches) 2015 The Bank of Maine as of 12/31/21 3 Year 5 Year 10 Year Total Return 47.

July 26, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 26, 2022 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission F

July 26, 2022 EX-99.1

CAMDEN NATIONAL CORPORATION REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS Camden National Corporation Reports Net Income of $15.0 Million for the Second Quarter of 2022 and 9% Loan Growth for the First Half of 2022

CONTACT: Michael Archer Executive Vice President Chief Financial Officer Camden National Corporation (800) 860-8821 marcher@camdennational.

June 28, 2022 EX-99.1

Camden National Corporation Announces its Second Quarter 2022 Dividend

CONTACT: Michael Archer Executive Vice President Chief Financial Officer Camden National Corporation (800) 860-8821 marcher@camdennational.

June 28, 2022 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 28, 2022 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission F

June 23, 2022 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 23, 2022 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission F

June 23, 2022 EX-99.1

• • • • • • • • • o o o o • • • • • • • • • • • • • Acquisitions: 2008 Union Bankshares 2012 Bank of America (14 branches) 2015 The Bank of Maine 3 Year 5 Year 10 Year Total Return 15.5% 28.0% 175.2% TBV/Sh CAGR 11.7% 10.0% 7.2% EPS CAGR 10.7% 12.3%

ex99 • • • • • • • • • o o o o • • • • • • • • • • • • • Acquisitions: 2008 Union Bankshares 2012 Bank of America (14 branches) 2015 The Bank of Maine 3 Year 5 Year 10 Year Total Return 15.

May 5, 2022 EX-10.7

Form of Executive Restricted Stock Award Agreement Under the 2022 Equity and Incentive Plan (incorporated herein by reference to Exhibit 10.7 to the Company's Quarterly Report on Form 10-Q filed with the Commission on May 5, 2022).

[EXECUTIVE] RESTRICTED STOCK AWARD AGREEMENT UNDER THE CAMDEN NATIONAL CORPORATION 2022 EQUITY AND INCENTIVE PLAN Name of Grantee: No.

May 5, 2022 EX-10.9

Form of Restricted Stock Unit Award Agreement for Company Employees Under the 2022 Equity and Incentive Plan with grant dates in 2022 (incorporated herein by reference to Exhibit 10.9 to the Company's Quarterly Report on Form 10-Q filed with the Commission on May 5, 2022).

RESTRICTED STOCK UNIT AWARD AGREEMENT FOR COMPANY EMPLOYEES UNDER THE CAMDEN NATIONAL CORPORATION 2022 EQUITY AND INCENTIVE PLAN Name of Grantee: [GRANTEE NAME] No.

May 5, 2022 EX-10.4

Camden National Corporation Third Amended and Restated Defined Contribution Retirement Program, effective as of April 26, 2022 (incorporated herein by reference to Exhibit 10.4 to the Company's Quarterly Report on Form 10-Q filed with the Commission on May 5, 2022).

CAMDEN NATIONAL CORPORATION THIRD AMENDED AND RESTATED DEFINED CONTRIBUTION RETIREMENT PROGRAM Effective April 26, 2022 This Camden National Corporation Third Amended and Restated Defined Contribution Retirement Program (the ?Program?), effective as of April 26, 2022 is an amendment and restatement of the Camden National Corporation Second Amended and Restated Defined Contribution Retirement Plan, effective as of January 30, 2018.

May 5, 2022 EX-10.3

Camden National Corporation Second Amended and Restated Management Stock Purchase Program, effective as of April 26, 2022 (incorporated herein by reference to Exhibit 10.3 to the Company's Quarterly Report on Form 10-Q filed with the Commission on May 5, 2022).

CAMDEN NATIONAL CORPORATION SECOND AMENDED AND RESTATED MANAGEMENT STOCK PURCHASE PROGRAM Effective April 26, 2022 I.

May 5, 2022 EX-10.5

Camden National Corporation Amended and Restated Independent Directors' Equity Compensation Program, effective as of April 26, 2022 (incorporated herein by reference to Exhibit 10.5 to the Company's Quarterly Report on Form 10-Q filed with the Commission on May 5, 2022).

CAMDEN NATIONAL CORPORATION AMENDED AND RESTATED INDEPENDENT DIRECTORS? EQUITY COMPENSATION PROGRAM Effective April 26, 2022 1.

May 5, 2022 EX-10.8

Form of Restricted Stock Award Agreement Under the Second Amended and Restated Management Stock Purchase Program (incorporated herein by reference to Exhibit 10.8 to the Company's Quarterly Report on Form 10-Q filed with the Commission on May 5, 2022).

RESTRICTED STOCK AWARD AGREEMENT UNDER THE CAMDEN NATIONAL CORPORATION SECOND AMENDED AND RESTATED MANAGEMENT STOCK PURCHASE PROGRAM Name of Grantee: No.

May 5, 2022 EX-10.6

Form of Non-Executive Restricted Stock Award Agreement Under the 2022 Equity and Incentive Plan (incorporated herein by reference to Exhibit 10.6 to the Company's Quarterly Report on Form 10-Q filed with the Commission on May 5, 2022).

[NON-EXECUTIVE] RESTRICTED STOCK AWARD AGREEMENT UNDER THE CAMDEN NATIONAL CORPORATION 2022 EQUITY AND INCENTIVE PLAN Name of Grantee: No.

May 5, 2022 EX-10.10

Form of Performance Share Unit Award Agreement Under the Second Amended and Restated Long-Term Performance Share Program (incorporated herein by reference to Exhibit 10.10 to the Company's Quarterly Report on Form 10-Q filed with the Commission on May 5, 2022).

PERFORMANCE SHARE UNIT AWARD AGREEMENT UNDER THE CAMDEN NATIONAL CORPORATION SECOND AMENDED AND RESTATED LONG-TERM PERFORMANCE SHARE UNIT PROGRAM Name of Grantee: No.

May 5, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 0-28190 CAMDEN NATIONAL CORPORATION (Exact name of registrant as spe

May 5, 2022 EX-10.11

Form of Incentive Stock Option Agreement Under the Camden National Corporation 2022 Equity and Incentive Plan (incorporated herein by reference to Exhibit 10.11 to the Company's Quarterly Report on Form 10-Q filed with the Commission on May 5, 2022).

EX-10.11 10 a33122exhibit1011.htm EX-10.11 INCENTIVE STOCK OPTION AGREEMENT UNDER THE CAMDEN NATIONAL CORPORATION 2022 EQUITY AND INCENTIVE PLAN Name of Optionee: [●] No. of Option Shares: [●] Option Exercise Price per Share: $[●] Grant Date: [●] Expiration Date: [●] Pursuant to the Camden National Corporation 2022 Equity and Incentive Plan, as amended through the date hereof (the “Plan”), Camden

April 28, 2022 S-8

As filed with the Securities and Exchange Commission on April 28, 2022 Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT The Securities Act of 1933 Camden National

As filed with the Securities and Exchange Commission on April 28, 2022 Registration Statement No.

April 28, 2022 EX-3.4

Camden National Corporation Amended and Restated Bylaws (incorporated herein by reference to Exhibit 3.4 to the Company's Registration Statement on Form S-8 filed with the Commission on April 28, 2022 (File No. 333-264534)).

CAMDEN NATIONAL CORPORATION AMENDED AND RESTATED BYLAWS ARTICLE I General Section 1.

April 28, 2022 EX-FILING FEES

Calculation of Filing Fee.

EX-FILING FEES 2 ex107feecalculation.htm EX-FILING FEES Exhibit 107 CALCULATION OF FILING FEE TABLE Form S-8 Camden National Corporation Title of Securities to be Registered Amount to be Registered(1) Proposed Maximum Offering Price Per Share(2) Proposed Maximum Aggregate Offering Price(2) Amount of Registration Fee Common stock, no par value 700,000 $46.97 $32,879,000 $3,047.88 (1) This Registrat

April 28, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 26, 2022 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission

April 28, 2022 EX-10.1

Camden National Corporation Second Amended and Restated Long-Term Performance Share Program, effective as of April 26, 2022 (incorporated herein by reference to Exhibit 10.1 to the Company's Form 8-K filed with the Commission on April 28, 2022).

CAMDEN NATIONAL CORPORATION SECOND AMENDED AND RESTATED LONG-TERM PERFORMANCE SHARE PROGRAM Effective April 26, 2022 1.

April 28, 2022 S-8 POS

As filed with the Securities and Exchange Commission on April 28, 2022

As filed with the Securities and Exchange Commission on April 28, 2022 Registration Statement No.

April 28, 2022 EX-99.1

Camden National Corporation 2022 Equity and Incentive Plan (incorporated herein by reference to Exhibit 99.1 to the Company's Registration Statement on Form S-8 filed with the Commission on April 28, 2022).

CAMDEN NATIONAL CORPORATION 2022 EQUITY AND INCENTIVE PLAN Table of Contents Page GENERAL PURPOSE OF THE PLAN 1 SECTION 1 DEFINITIONS 1 SECTION 2 ADMINISTRATION 5 (a) Committee.

April 28, 2022 EX-3.3

Amendment to the Articles of Incorporation of Camden National Corporation (incorporated herein by reference to Exhibit 3.3 to the Company's Registration Statement on Form S-8 filed with the Commission on April 28, 2022 (File No. 333-264534)).

April 26, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 26, 2022 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission

April 26, 2022 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 26, 2022 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission

April 26, 2022 EX-99.1

CAMDEN NATIONAL CORPORATION REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS Camden National Reports a 2% Increase in Net Income and Diluted EPS for the First Quarter of 2022 over the Fourth Quarter of 2021

CONTACT: Michael Archer Executive Vice President Chief Financial Officer Camden National Corporation (800) 860-8821 marcher@camdennational.

April 26, 2022 EX-99.1

Presenters: Larry Sterrs Director and Chair of the Board of Directors Greg Dufour President and Chief Executive Officer Mike Archer Chief Financial Officer Recording Secretary: Joanne Campbell Executive Vice President, Enterprise Risk Management and

Presenters: Larry Sterrs Director and Chair of the Board of Directors Greg Dufour President and Chief Executive Officer Mike Archer Chief Financial Officer Recording Secretary: Joanne Campbell Executive Vice President, Enterprise Risk Management and Chief Risk Officer Inspector of Election: Brandon Boey Senior Vice President, Legal Affairs and BSA Officer ? ? ? ? ? ? 38.

April 1, 2022 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

DEFA14A 1 proxyapril2022.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, For Use of the Commission Only o Definitive Proxy Sta

March 29, 2022 EX-99.1

Camden National Corporation Announces its First Quarter 2022 Dividend

CONTACT: Michael Archer Executive Vice President Chief Financial Officer Camden National Corporation (800) 860-8821 marcher@camdennational.

March 29, 2022 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 29, 2022 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission

March 15, 2022 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, For Use of the Commission Only ? Definitive Proxy Statement o Definitive Additional Materi

March 11, 2022 EX-21.1

Subsidiaries of

Exhibit 21.1 Camden National Bank, a national banking organization organized under the laws of the United States of America. Healthcare Professional Funding Corporation, a wholly-owned subsidiary of Camden National Bank Property A, a wholly-owned subsidiary of Camden National Bank

March 11, 2022 EX-10.14

Camden National Corporation Nonqualified Deferred Compensation Plan (incorporated herein by reference to Exhibit 10.14 to the Company's Annual Report on Form 10-K filed with the Commission on March 11, 2022).

THE NONQUALIFIED DEFERRED COMPENSATION PLAN PLAN DOCUMENT THE NONQUALIFIED DEFERRED COMPENSATION PLAN Section 1.

March 11, 2022 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 0-28190 CAMDEN NATIONAL CORPORATION (Exact Name of Registrant As Specified i

March 11, 2022 EX-10.15

Camden National Corporation Nonqualified Deferred Compensation Plan Adoption Agreement (incorporated herein by reference to Exhibit 10.15 to the Company's Annual Report on Form 10-K filed with the Commission on March 11, 2022).

/.NOTE: Execution of this Adoption Agreement creates a legal liability of the Employer with significant tax consequences to the Employer and Participants. Principal Life Insurance Company disclaims all liability for the legal and tax consequences which result from the elections made by the Employer in this Adoption Agreement. Nothing set forth in this agreement or related documents may be taken or

March 11, 2022 EX-4.1

Description of Camden National Corporation's Securities Registered under Section 12 of the Exchange Act.

Exhibit 4.1 DESCRIPTION OF CAPITAL STOCK A brief summary of the material terms of our capital stock is set forth below. The description is qualified in its entirety by reference to our Articles of Incorporation, as amended (the ?Articles?) and Amended and Restated Bylaws (the ?Bylaws?) that are filed as exhibits to the Form 10-K of which this Exhibit is a part. The following description of our cap

March 2, 2022 PRE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

PRE 14A 1 proxy2022.htm PRE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: ý Preliminary Proxy Statement o Confidential, For Use of the Commission Only o Definitive Proxy Statemen

February 8, 2022 SC 13G/A

CAC / Camden National Corporation / DIMENSIONAL FUND ADVISORS LP - SEC SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3 )* Camden National Corp (Name of Issuer) Common Stock (Title of Class of Securities) 133034108 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this S

January 25, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 25, 2022 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commissio

January 25, 2022 EX-99.1

CAMDEN NATIONAL CORPORATION REPORTS FOURTH QUARTER AND YEAR END 2021 FINANCIAL RESULTS Camden National Reports Record Net Income of $69.0 Million for 2021; Net Income of $16.5 million for the Fourth Quarter of 2021

CONTACT: Michael Archer Executive Vice President Chief Financial Officer Camden National Corporation (800) 860-8821 marcher@camdennational.

January 3, 2022 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 27, 2021 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commissi

December 21, 2021 EX-99.1

Camden National Corporation Announces an 11% Increase in its Fourth Quarter 2021 Dividend

EX-99.1 2 exhibit991pressrelease1221.htm EX-99.1 CONTACT: Michael Archer Corporate Controller Camden National Bank (800) 860-8821 [email protected] FOR IMMEDIATE RELEASE Camden National Corporation Announces an 11% Increase in its Fourth Quarter 2021 Dividend CAMDEN, Maine, December 21, 2021 /PRNewswire/ - Gregory A. Dufour, president and chief executive officer of Camden National Corpora

December 21, 2021 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 21, 2021 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commissi

December 13, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 13, 2021 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commissi

November 4, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 0-28190 CAMDEN NATIONAL CORPORATION (Exact name of registrant as

October 26, 2021 EX-99.1

CAMDEN NATIONAL CORPORATION REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS Camden National Corporation Reports Net Income of $52.5 Million for the Nine Months Ended September 30, 2021 and $14.6 Million for the Third Quarter of 2021

EX-99.1 2 ex991earningsreleaseq321.htm EX-99.1 CONTACT: Michael Archer Senior Vice President Corporate Controller Camden National Corporation (800) 860-8821 [email protected] FOR IMMEDIATE RELEASE CAMDEN NATIONAL CORPORATION REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS Camden National Corporation Reports Net Income of $52.5 Million for the Nine Months Ended September 30, 2021 and $14.6 Mi

October 26, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 26, 2021 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commissio

October 26, 2021 EX-99.2

Financial Highlights (unaudited) Three Months Ended September 30, Nine Months Ended September 30, (Dollars in thousands, except per share data) 2021 2020 2021 2020 Earnings and Dividends Net interest income $ 34,746 $ 34,481 $ 100,639 $ 100,846 Non-i

Third Quarter Report - 2021 Dear Fellow Shareholders: During the third quarter, like most of the world, Camden National Corporation experienced the highs and lows of the environment driven by the pandemic and related economic conditions.

September 28, 2021 EX-99.1

Camden National Corporation Announces its Third Quarter 2021 Dividend

CONTACT: Michael Archer Corporate Controller Camden National Bank (800) 860-8821 marcher@camdennational.

September 28, 2021 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 28, 2021 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commiss

September 8, 2021 EX-99.1

• • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • TBV Per Share(a) Dividends as a % of Net Income • • • • 15 Year Stock price appreciation

? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? TBV Per Share(a) Dividends as a % of Net Income ? ? ? ? 15 Year Stock price appreciation of 60.

September 8, 2021 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 8, 2021 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commissi

August 5, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 0-28190 CAMDEN NATIONAL CORPORATION (Exact name of registrant as spec

August 3, 2021 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 3, 2021 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission

August 3, 2021 EX-99.1

1 Investor Presentation Gregory Dufour | President & Chief Executive Officer Gregory White | Chief Financial Officer August 3, 2021 2 Forward Looking Statements This presentation contains certain statements that may be considered forward-looking stat

1 Investor Presentation Gregory Dufour | President & Chief Executive Officer Gregory White | Chief Financial Officer August 3, 2021 2 Forward Looking Statements This presentation contains certain statements that may be considered forward-looking statements under the Private Securities Litigation Reform Act of 1995 and other federal securities laws, including certain plans, exceptions, goals, projections, and statements, which are subject to numerous risks, assumptions, and uncertainties.

July 27, 2021 EX-99.2

Financial Highlights (unaudited) Three Months Ended June 30, Six Months Ended June 30, (Dollars in thousands, except per share data) 2021 2020 2021 2020 Earnings and Dividends Net interest income $ 33,529 $ 34,539 $ 65,893 $ 66,365 Non-interest incom

Second Quarter Report - 2021 Dear Fellow Shareholders: As we mark the halfway point of 2021, we remain committed to delivering upon our strategic investments and our employees? unwavering dedication to our customers and communities.

July 27, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 27, 2021 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission F

July 27, 2021 EX-99.1

CAMDEN NATIONAL CORPORATION REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS Camden National Corporation Reports Net Income of $18.1 Million for the Second Quarter of 2021 and $37.9 Million for the Six Months Ended June 30, 2021

CONTACT: Michael Archer Senior Vice President Corporate Controller Camden National Corporation (800) 860-8821 marcher@CamdenNational.

June 29, 2021 EX-99.1

Camden National Corporation Announces its Second Quarter 2021 Dividend

CONTACT: Michael Archer Corporate Controller Camden National Bank (800) 860-8821 marcher@camdennational.

June 29, 2021 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 29, 2021 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission F

June 24, 2021 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 24, 2021 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission F

June 24, 2021 EX-99.1

• • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • Fee income is 32% of total revenue (net interest income plus fee income) • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • TBV Per Share(a) Dividends as a % of

? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? Fee income is 32% of total revenue (net interest income plus fee income) ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? TBV Per Share(a) Dividends as a % of Net Income ? ? ? ? ? Stock price appreciation of 75.

June 17, 2021 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 17, 2021 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission F

June 17, 2021 EX-99.1

PO Box 310 | Camden, Maine 04843 | 800.860.8821 | CamdenNational.com

June 18, 2021 Dear Shareholder, I?m writing to share an important update regarding Camden National Corporation?s transfer agent.

May 6, 2021 10-Q

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 0-28190 CAMDEN NATIONAL CORPORATION (Exact name of registrant as spe

April 29, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 27, 2021 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission

April 29, 2021 EX-10.1

Camden National Corporation 2021-2023 amended and restated Long-Term Performance Share Plan.

EX-10.1 2 ex1012021ltip.htm EX-10.1 CAMDEN NATIONAL CORPORATION AMENDED AND RESTATED LONG-TERM PERFORMANCE SHARE PLAN 1. Purpose. This Plan is intended to create incentives for certain executive officers of Camden National Corporation (the “Company”) to attract and retain its employees who will contribute to the future success of the Company. It is further the intent of the Company that Awards mad

April 27, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 27, 2021 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission

April 27, 2021 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 27, 2021 Camden National Corporation (Exact name of registrant as specified in its charter) Maine 01-28190 01-0413282 (State or other jurisdiction of incorporation) (Commission

Other Listings
DE:3LR € 34.40
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista